Sexually Transmitted Infections (STIs) Market Analysis and Trends 2024

 The sexually transmitted infections (stis) global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Sexually Transmitted Infections (STIs) Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size —
The sexually transmitted infections (stis) market size has grown rapidly in recent years. It will grow from $56.17 billion in 2023 to $63.69 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to behavioral factors, education and awareness, healthcare access, antibiotic development.

The sexually transmitted infections (stis) market size is expected to see rapid growth in the next few years. It will grow to $100.66 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to emerging sti strains, vaccination initiatives, telemedicine and at-home testing, sexual health equity. Major trends in the forecast period include rise of antimicrobial resistance, pre-exposure prophylaxis (prep), sti self-management, enhanced sexual education.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

Scope Of Sexually Transmitted Infections (STIs) Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Sexually Transmitted Infections (STIs) Market Overview

Market Drivers –
The surge in government initiatives for spreading awareness of sexually transmitted infections is expected to propel the growth of the sexually transmitted infections (STIs) market going forward. A government initiative is a program or policy implemented to achieve a specific goal and address particular problems. The government offers several initiatives to prevent, control and treat sexually transmitted infections (STIs), such as funds for public education campaigns to raise awareness of STIs, vaccines to prevent certain STIs and free or low-cost screening and testing. For instance, in April 2023, Springfield-Greene County Health, a US-based public health department, announced Disease Intervention Specialist (DIS), a new program and partnership with the Missouri Department of Health and Senior Services (Missouri DHSS) to combat the rising spread of sexually transmitted infections (STIs) in Greene County. The two experts in the DIS program, who will primarily focus on syphilis and HIV, will contact those who test positive for these illnesses, connect them with options for treatment and help identify and get in touch with them to make them aware of the infection. Therefore, the surge in government initiatives will drive the sexually transmitted infections (STIs) market.

Market Trends —
Major companies operating in the sexually transmitted infections (STIs) market are developing innovative products with fluorescent PCR technology to gain a competitive advantage in the market. Fluorescent PCR (Polymerase Chain Reaction) technology is a molecular biology technique that detects and quantifies specific DNA sequences in a biological sample. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of molecular diagnostic solutions, introduced two new polymer chain reaction (PCR) kits, Mycoplasma Hominis Real-Time PCR Kit and Treponema Pallidum Real-Time PCR Kit. These Kits provide a complete PCR solution for early diagnosis of sexually transmitted illnesses, which impact many individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent that uses fluorescent PCR technology to detect Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs and urine samples. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is designed to detect treponema pallidum nucleic acid in human serum and plasma.

The sexually transmitted infections (stis) market covered in this report is segmented –

1) By Type: Human Immunodeficiency Virus (HIV); Human Papilloma Virus (HPV); Gonorrhea; Syphilis; Other Types
2) By Treatment: Antibiotics; Antiviral
3) By Location Of Testing: Laboratory Testing; Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users

Get an inside scoop of the sexually transmitted infections (stis) market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp

Regional Insights —
North America was the largest region in the sexually transmitted infection (STIs) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies —
Major players in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

Table of Contents
1. Executive Summary
2. Sexually Transmitted Infections (STIs) Market Report Structure
3. Sexually Transmitted Infections (STIs) Market Trends And Strategies
4. Sexually Transmitted Infections (STIs) Market — Macro Economic Scenario
5. Sexually Transmitted Infections (STIs) Market Size And Growth
…..
27. Sexually Transmitted Infections (STIs) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model